Clinical Trial Update: Intron A for the Treatment of Hypertrophic Scar [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Intron A for burn injuries and hypertrophic scars has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Injury
• Hypertrophic Scar

Drugs mentioned

• Intron A (interferon alfa-2b)

Snippet

Sponsor: University of Alberta | Conditions: Burn, Hypertrophic Scar | Phase 3 | Status: WITHDRAWN